Guizhou Sanli Pharmaceutical Co.,Ltd

Informe acción SHSE:603439

Capitalización de mercado: CN¥5.3b

Guizhou Sanli PharmaceuticalLtd Dirección

Dirección controles de criterios 4/4

El CEO de Guizhou Sanli PharmaceuticalLtd es Hai Zhang, nombrado en Jan 2015, tiene una permanencia de 9.83 años. posee directamente un 44.67% de las acciones de la empresa, con un valor de CN¥2.38B. La antigüedad media del equipo directivo y de la junta directiva es de 5.3 años y 5.1 años, respectivamente.

Información clave

Hai Zhang

Chief Executive Officer (CEO)

CN¥758.0k

Compensación total

Porcentaje del salario del CEOn/a
Permanencia del CEO9.8yrs
Participación del CEO44.7%
Permanencia media de la dirección5.3yrs
Promedio de permanencia en la Junta Directiva5.1yrs

Actualizaciones recientes de la dirección

Recent updates

We Ran A Stock Scan For Earnings Growth And Guizhou Sanli PharmaceuticalLtd (SHSE:603439) Passed With Ease

Oct 16
We Ran A Stock Scan For Earnings Growth And Guizhou Sanli PharmaceuticalLtd (SHSE:603439) Passed With Ease

Little Excitement Around Guizhou Sanli Pharmaceutical Co.,Ltd's (SHSE:603439) Earnings

Aug 25
Little Excitement Around Guizhou Sanli Pharmaceutical Co.,Ltd's (SHSE:603439) Earnings

Is Guizhou Sanli Pharmaceutical Co.,Ltd (SHSE:603439) Trading At A 20% Discount?

Aug 03
Is Guizhou Sanli Pharmaceutical Co.,Ltd (SHSE:603439) Trading At A 20% Discount?

Guizhou Sanli Pharmaceutical Co.,Ltd's (SHSE:603439) Intrinsic Value Is Potentially 73% Above Its Share Price

Apr 23
Guizhou Sanli Pharmaceutical Co.,Ltd's (SHSE:603439) Intrinsic Value Is Potentially 73% Above Its Share Price

Guizhou Sanli PharmaceuticalLtd (SHSE:603439) Seems To Use Debt Rather Sparingly

Mar 25
Guizhou Sanli PharmaceuticalLtd (SHSE:603439) Seems To Use Debt Rather Sparingly

Guizhou Sanli Pharmaceutical Co.,Ltd's (SHSE:603439) Price Is Right But Growth Is Lacking After Shares Rocket 26%

Mar 06
Guizhou Sanli Pharmaceutical Co.,Ltd's (SHSE:603439) Price Is Right But Growth Is Lacking After Shares Rocket 26%

CEO

Hai Zhang (38 yo)

9.8yrs

Permanencia

CN¥758,000

Compensación

Mr. Hai Zhang is Chairman & GM of Guizhou Sanli Pharmaceutical Co.,Ltd from January 2015.


Equipo directivo

NombrePosiciónPermanenciaCompensaciónPropiedad
Hai Zhang
Chairman & GM9.8yrsCN¥758.00k44.67%
CN¥ 2.4b
Hongyu Zhang
CFO, Head of Accounting & Director9.8yrsCN¥462.30k0.065%
CN¥ 3.5m
Yuan Yu
Deputy General Manager3.5yrsCN¥465.60k0.019%
CN¥ 998.9k
Yi Wang
Deputy General Manager6.7yrsCN¥461.80k0.23%
CN¥ 12.5m
Ke Guo
Deputy General Manager3.8yrsCN¥537.00k0.060%
CN¥ 3.2m
Qianfan Zhang
Vice Chairman & Board Secretary6.7yrsCN¥578.20k0.12%
CN¥ 6.2m
Jing Long
Chairman of the Supervisory Board & Manager of Human Resources Department3.5yrsCN¥314.20ksin datos
Donghai Liang
Supervisor & Business Manager2yrsCN¥300.30ksin datos

5.3yrs

Permanencia media

38.5yo

Promedio de edad

Equipo directivo experimentado: El equipo directivo de 603439 es experimentado (5.3 años antigüedad media).


Miembros de la Junta

NombrePosiciónPermanenciaCompensaciónPropiedad
Hai Zhang
Chairman & GM9.8yrsCN¥758.00k44.67%
CN¥ 2.4b
Hongyu Zhang
CFO, Head of Accounting & Director9.8yrsCN¥462.30k0.065%
CN¥ 3.5m
Qianfan Zhang
Vice Chairman & Board Secretary6.7yrsCN¥578.20k0.12%
CN¥ 6.2m
Jing Long
Chairman of the Supervisory Board & Manager of Human Resources Department3.5yrsCN¥314.20ksin datos
Donghai Liang
Supervisor & Business Manager2yrsCN¥300.30ksin datos
Yongjian Sheng
Director9.8yrssin datos5.48%
CN¥ 292.0m
Shi Gui Chen
Independent Director1.9yrsCN¥60.00ksin datos
Wang Qiang
Independent Director1.9yrsCN¥60.00ksin datos

5.1yrs

Permanencia media

45yo

Promedio de edad

Junta con experiencia: La junta directiva de 603439 se considera experimentada (5.1 años de antigüedad promedio).